August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden, Schumer, Warren Sound Alarm Over Trump Weaponization of the IRS Against the Free Speech Rights of Trump Opponents
- Finance Democrats Call for Halt to Unlawful Nomination of March Bell to be Health Care Inspector General
- Wyden, Welch, Cortez Masto Introduce Bill to Block Republicans’ Big Pharma Bailout, Protect Access to Life-Saving Prescription Drugs
- New CBO Report: Trump's Big Ugly Bill Includes $8.8 Billion Handout for Pharmaceutical Companies
- With JPMorgan Chase Dodging Epstein Inquiry, Wyden Investigation Drills Down On Bank Executives’ Unexplained Conduct